The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to receive the World Health Organisation (WHO) validation for emergency use since the pandemic outbreak.
“Regulatory experts from around the world reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy and quality. They found that the vaccine met the must-have criteria for safety, efficacy and that the benefits of using it to address the disease offset potential risks,” WHO Tweeted.
The Pfizer/BioNTech #COVID19 vaccine today became the first vaccine to receive WHO validation for emergency use since the outbreak began.
— World Health Organization (WHO) (@WHO) December 31, 2020
Equitable global access to vaccines is crucial to combat the pandemic.
👉 https://t.co/7WNcHhc3z8 pic.twitter.com/Kyjv5RNzjB
Regulatory experts from around the 🌐 reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy & quality. They found that the vaccine met the must-have criteria for safety & efficacy & that the benefits of using it to address the disease offset potential risks pic.twitter.com/XSCQIDlw9b
— World Health Organization (WHO) (@WHO) December 31, 2020
Ukraine accuses SpaceX of crippling drone missions as ties with US worsen
Kenya reports second Ebola case, family member of first patient
Debris from intercepted Houthi missiles injure 4, damage 15 homes in Riyadh
India's 'cockroach' movement leaders detained in jail for 5 days
Saudi Aramco administrative building targeted, minor blaze reported
